SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-007396
Filing Date
2023-05-01
Accepted
2023-05-01 07:45:38
Documents
16
Period of Report
2023-05-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sngx-20230501x8k.htm   iXBRL 8-K 38097
2 EX-99.1 sngx-20230501xex99d1.htm EX-99.1 31525
3 GRAPHIC sngx-20230501xex99d1001.jpg GRAPHIC 14345
  Complete submission text file 0001558370-23-007396.txt   314570

Data Files

Seq Description Document Type Size
4 EX-101.SCH sngx-20230501.xsd EX-101.SCH 4052
5 EX-101.DEF sngx-20230501_def.xml EX-101.DEF 3492
6 EX-101.LAB sngx-20230501_lab.xml EX-101.LAB 632
7 EX-101.PRE sngx-20230501_pre.xml EX-101.PRE 10408
10 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20230501x8k_htm.xml XML 4794
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 23870054
SIC: 2834 Pharmaceutical Preparations